SCHEMBL5818029

SCHEMBL5818029

OC1(c2nc(-c3cccc(Cl)c3)c(-c3ccnc(NC4CCCCC4)n3)s2)CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.45
IKBKB O14920 1/20 0.44
MAPK8 P45983 4/20 0.41
MAPK9 P45984 4/20 0.41
MAPK10 P53779 3/20 0.41
KDR P35968 3/20 0.41
CDK1 P06493 3/20 0.41
MAPK1 P28482 2/20 0.41
PLK4 O00444 2/20 0.41
PIM1 P11309 2/20 0.41
PRKACA P17612 2/20 0.41
FLT3 P36888 2/20 0.41
GSK3B P49841 2/20 0.41
IRAK4 Q9NWZ3 2/20 0.41
AKT3 Q9Y243 2/20 0.41
CDK2 P24941 2/20 0.41
CHEK1 O14757 1/20 0.41
MAPK13 O15264 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKCG P05129 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813597 0.99 ADORA1 (0.46) ADORA1IKBKBMAPK8MAPK9MAPK10
SCHEMBL5819084 0.96 IKBKB (0.46) ADORA1IKBKBMAPK8MAPK9MAPK10
SCHEMBL5814640 0.90 BRAF (0.47) IKBKBMAPK8MAPK9MAPK10KDR
SCHEMBL5817822 0.90 MAPK14 (0.46) IKBKBMAPK8MAPK9MAPK10KDR
SCHEMBL5813948 0.89 MAPK14 (0.46) IKBKBMAPK8MAPK9MAPK10KDR
SCHEMBL5814974 0.89 BRAF (0.47) IKBKBMAPK8MAPK9KDREGFR
SCHEMBL5818423 0.89 MAPK9 (0.46) ADORA1IKBKBMAPK8MAPK9MAPK10
SCHEMBL5819550 0.88 MAPK9 (0.47) MAPK8MAPK9KDRCDK1CDK2
SCHEMBL5812484 0.88 MAPK9 (0.47) ADORA1IKBKBMAPK8MAPK9MAPK10
SCHEMBL5819553 0.87 MAPK9 (0.48) MAPK9CDK1PIM1CDK2MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed